RU2014140852A - Растительная композиция для лечения нарушений обмена веществ - Google Patents

Растительная композиция для лечения нарушений обмена веществ Download PDF

Info

Publication number
RU2014140852A
RU2014140852A RU2014140852A RU2014140852A RU2014140852A RU 2014140852 A RU2014140852 A RU 2014140852A RU 2014140852 A RU2014140852 A RU 2014140852A RU 2014140852 A RU2014140852 A RU 2014140852A RU 2014140852 A RU2014140852 A RU 2014140852A
Authority
RU
Russia
Prior art keywords
composition
extract
composition according
calophyllum
plant
Prior art date
Application number
RU2014140852A
Other languages
English (en)
Russian (ru)
Inventor
Арвинд САКЛАНИ
Парикшит ГАЙКВАД
Аслам БУРХАН
Сомеш ШАРМА
Original Assignee
Пирамал Энтерпрайзис Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пирамал Энтерпрайзис Лимитед filed Critical Пирамал Энтерпрайзис Лимитед
Publication of RU2014140852A publication Critical patent/RU2014140852A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
RU2014140852A 2012-03-13 2013-03-12 Растительная композиция для лечения нарушений обмена веществ RU2014140852A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261610002P 2012-03-13 2012-03-13
US61/610,002 2012-03-13
PCT/IB2013/051925 WO2013136257A1 (en) 2012-03-13 2013-03-12 Herbal composition for the treatment of metabolic disorders

Publications (1)

Publication Number Publication Date
RU2014140852A true RU2014140852A (ru) 2016-05-10

Family

ID=49160323

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2014140852A RU2014140852A (ru) 2012-03-13 2013-03-12 Растительная композиция для лечения нарушений обмена веществ

Country Status (13)

Country Link
US (1) US20150050373A1 (enExample)
EP (1) EP2825183A4 (enExample)
JP (1) JP2015509976A (enExample)
KR (1) KR20140138275A (enExample)
CN (1) CN104203258A (enExample)
AU (1) AU2013233930A1 (enExample)
CA (1) CA2866260A1 (enExample)
IL (1) IL234616A0 (enExample)
IN (1) IN2014MN01933A (enExample)
MX (1) MX2014010926A (enExample)
NZ (1) NZ630125A (enExample)
RU (1) RU2014140852A (enExample)
WO (1) WO2013136257A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109069475B (zh) 2016-04-22 2022-01-28 受体控股公司 快速作用植物类医药化合物和营养补剂
EA201892396A1 (ru) 2016-12-02 2019-04-30 Ресептор Лайф Сайенсиз, Инк. Быстродействующие растительные лекарственные соединения и биологически активные добавки
US12303487B2 (en) 2018-11-19 2025-05-20 Spoke Sciences, Inc. N-acylated fatty amino acids to reduce absorption variability in cannabinoid based compositions
US20220214367A1 (en) * 2019-04-15 2022-07-07 Board Of Regents, The University Of Texas System Calibration methods and compositions for biomolecule analysis

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211944A (en) * 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
US6774141B1 (en) * 1992-03-31 2004-08-10 The United States Of America As Represented By The Secretary Of Health And Human Services Calanolide and related antiviral compounds, compositions, and uses thereof
JP4195728B2 (ja) * 1996-10-16 2008-12-10 ナポ ファーマシューティカルズ,インコーポレーテッド プロアントシアニジンポリマー止瀉組成物の腸溶製剤
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
FR2794973B1 (fr) * 1999-06-18 2001-09-14 Mousny Brigitte Utilisation d'huile de plantes du genre calophyllum extraite a temperature ambiante dans des compositions cosmetiques, dietetiques et therapeutiques
JP2001192317A (ja) * 2000-01-06 2001-07-17 Shiseido Co Ltd マトリックスメタロプロテアーゼ阻害剤
JP2005272326A (ja) * 2004-03-23 2005-10-06 A Pharma Kindai Co Ltd 抗アレルギー剤、抗掻痒剤、及び抗菌剤
FR2886547B1 (fr) * 2005-06-02 2009-06-05 Boucher Claude Henri Marie Ghi Composition cosmetique, dietetique, pharmaceutique obtenue a partir d'huile non raffinee exempte d'acides gras trans, d'esters phorboliques, extraite sans solvant
PT2529626T (pt) * 2006-05-01 2018-02-27 Napo Pharmaceuticals Inc Composições e métodos para tratamento ou prevenção do cancro do cólon
JP2008081440A (ja) * 2006-09-27 2008-04-10 Noevir Co Ltd アロマターゼ活性促進剤
AU2007336238A1 (en) * 2006-12-20 2008-06-26 Novartis Ag 2-substituted 5-membered heterocycles as SCD inhibitors
FR2915095B1 (fr) * 2007-04-17 2013-08-23 Diaye Yacine Isabelle Monique N Creme de soin
US20100135945A1 (en) * 2008-12-02 2010-06-03 Kreations By Kristin, Llc Gymnema-containing lip balm compositions and associated methods
US8821948B2 (en) * 2010-03-04 2014-09-02 Steva A. Komeh-Nkrumah Therapeutic, bio-affecting and body treating composition

Also Published As

Publication number Publication date
CN104203258A (zh) 2014-12-10
NZ630125A (en) 2017-01-27
IN2014MN01933A (enExample) 2015-07-10
JP2015509976A (ja) 2015-04-02
AU2013233930A1 (en) 2014-09-25
KR20140138275A (ko) 2014-12-03
EP2825183A1 (en) 2015-01-21
US20150050373A1 (en) 2015-02-19
CA2866260A1 (en) 2013-09-19
EP2825183A4 (en) 2015-09-23
MX2014010926A (es) 2015-04-10
IL234616A0 (en) 2014-11-30
WO2013136257A1 (en) 2013-09-19

Similar Documents

Publication Publication Date Title
RU2014145931A (ru) Композиция для лечения нарушений метаболизма
Gavamukulya et al. Annona muricata: Is the natural therapy to most disease conditions including cancer growing in our backyard? A systematic review of its research history and future prospects
JP2015514797A5 (enExample)
Niroumand et al. Medicinal properties of Peganum harmala L. in traditional Iranian medicine and modern phytotherapy: a review
Baliga Review of the phytochemical, pharmacological and toxicological properties of Alstonia scholaris Linn. R. Br (Saptaparna)
RU2020123679A (ru) Композиции и способы лечения и/или предотвращения сердечно-сосудистого заболевания
Peer et al. Cardioprotective effect of Azadirachta indica A. Juss. on isoprenaline induced myocardial infarction in rats
CN104592025B (zh) 一种阿魏酸酯类化合物及其制备方法
NZ711283A (en) Compositions and methods for lowering triglycerides without raising ldl-c levels
GB2465897A (en) Respiratory disease treatment
Velázquez-González et al. Antinociceptive and anti-inflammatory activities of Geranium bellum and its isolated compounds
Galeotti et al. St. John's Wort seed and feverfew flower extracts relieve painful diabetic neuropathy in a rat model of diabetes
CN102218049B (zh) 抗衰老的药物或保健食品组合物及用途
Bolanle et al. Hepatocurative potential of Vitex doniana root bark, stem bark and leaves extracts against CCl4–induced liver damage in rats
WO2013022279A3 (en) N1-cyclic amine-n5-substituted biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same
RU2015109566A (ru) НОВЫЕ ЭКСТРАКТЫ ИЗ CYNARA SCOLYMUS, COFFEA spp. И OLEA EUROPAEA ДЛЯ ЛЕЧЕНИЯ МЕТАБОЛИЧЕСКОГО СИНДРОМА
DK2244703T3 (da) Lægemiddel og fremstillingen og anvendelse deraf i behandlingen af smertefulde neuropatier
JP6335373B2 (ja) 脂質異常症の治療用のチョウセンアザミの抽出物
WO2012042197A3 (en) Low dose pharmaceutical composition comprising zanamivir
Venkatesh et al. Influence of piperine on ibuprofen inducedantinociception and its pharmacokinetics
RU2012131959A (ru) Способ лечения остеоартрита
CN102119956B (zh) 降香油在制备抗人体病原菌药物中应用和降香香水
WO2016175589A3 (ko) 혼합 생약 추출물을 함유하는 호흡기 질환 예방 또는 치료용 약학적 조성물
Cho et al. Differential anti-inflammatory and analgesic effects by enantiomers of zaltoprofen in rodents
CN101134057B (zh) 含紫杉醇的天然植物提取物的复方药物及其抗癌应用

Legal Events

Date Code Title Description
FA94 Acknowledgement of application withdrawn (non-payment of fees)

Effective date: 20180219